Associated Papers
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.
Palafox M et al.
Nature Communications, 2022
36071033 (PubMed )
Supplement: 41467_2022_32828_MOESM4_ESM.xlsx › Fig_2A_and_Table_S4
A brain somatic RHEB doublet mutation causes focal cortical dysplasia type II.
Zhao S et al.
Experimental & Molecular Medicine, 2019
Select a paper to view details